Grifols expects to boost revenue and free cash flow, shares soar
BARCELONA (Reuters) – Spanish drugmaker Grifols said on Thursday it expects its revenue, core earnings and free cash flow to grow significantly in the coming years as it aims to leave behind a tumultuous 2024 when it lost more than 30% of its market value. …